| Mitochondrial dysfunction prevents repolarization of inflammatory macrophages J Van den Bossche, J Baardman, NA Otto, S van der Velden, AE Neele, ... Cell reports 17 (3), 684-696, 2016 | 727 | 2016 |
| Distribution of macrophage polarization markers in human atherosclerosis JL Stöger, MJJ Gijbels, S van der Velden, M Manca, CM van der Loos, ... Atherosclerosis 225 (2), 461-468, 2012 | 710 | 2012 |
| A proinflammatory gut microbiota increases systemic inflammation and accelerates atherosclerosis E Brandsma, NJ Kloosterhuis, M Koster, DC Dekker, MJJ Gijbels, ... Circulation research 124 (1), 94-100, 2019 | 285 | 2019 |
| Targeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesions MA Hoeksema, MJJ Gijbels, J Van den Bossche, S van der Velden, ... EMBO molecular medicine 6 (9), 1124-1132, 2014 | 169 | 2014 |
| A defective pentose phosphate pathway reduces inflammatory macrophage responses during hypercholesterolemia J Baardman, SGS Verberk, KHM Prange, M van Weeghel, ... Cell reports 25 (8), 2044-2052. e5, 2018 | 168 | 2018 |
| Epicardium and myocardium separate from a common precursor pool by crosstalk between bone morphogenetic protein–and fibroblast growth factor–signaling pathways B van Wijk, G van den Berg, R Abu-Issa, P Barnett, S van der Velden, ... Circulation research 105 (5), 431-441, 2009 | 140 | 2009 |
| The BMP antagonist follistatin-like 1 is required for skeletal and lung organogenesis M Sylva, VSW Li, AAA Buffing, JH van Es, M van den Born, ... PloS one 6 (8), e22616, 2011 | 115 | 2011 |
| Macrophage ATP citrate lyase deficiency stabilizes atherosclerotic plaques J Baardman, SGS Verberk, S Van der Velden, MJJ Gijbels, ... Nature communications 11 (1), 6296, 2020 | 90 | 2020 |
| Nanoparticle-aided characterization of arterial endothelial architecture during atherosclerosis progression and metabolic therapy TJ Beldman, TS Malinova, E Desclos, AE Grootemaat, ALS Misiak, ... ACS nano 13 (12), 13759-13774, 2019 | 86 | 2019 |
| IFN-γ priming of macrophages represses a part of the inflammatory program and attenuates neutrophil recruitment MA Hoeksema, BP Scicluna, M Boshuizen, S Van Der Velden, AE Neele, ... The Journal of Immunology 194 (8), 3909-3916, 2015 | 81 | 2015 |
| Inhibiting epigenetic enzymes to improve atherogenic macrophage functions J Van den Bossche, AE Neele, MA Hoeksema, F De Heij, MCS Boshuizen, ... Biochemical and biophysical research communications 455 (3-4), 396-402, 2014 | 75 | 2014 |
| Interferon-β promotes macrophage foam cell formation by altering both cholesterol influx and efflux mechanisms MCS Boshuizen, MA Hoeksema, AE Neele, S van der Velden, ... Cytokine 77, 220-226, 2016 | 44 | 2016 |
| LinRegPCR: Analysis of quantitative RT-PCR data [computer program] J Ruijter, S Van Der Velden, A Ilgun Amsterdam, Netherlands: Heart Failure Research Center, Academic Medical Centre, 2009 | 29 | 2009 |
| Myeloid Kdm6b deficiency results in advanced atherosclerosis AE Neele, MJJ Gijbels, S van der Velden, MA Hoeksema, ... Atherosclerosis 275, 156-165, 2018 | 26 | 2018 |
| Macrophage Kdm6b controls the pro-fibrotic transcriptome signature of foam cells AE Neele, KHM Prange, MA Hoeksema, S Van Der Velden, T Lucas, ... Epigenomics 9 (4), 383-391, 2017 | 26 | 2017 |
| Helminth antigens counteract a rapid high-fat diet-induced decrease in adipose tissue eosinophils SM van den Berg, AD van Dam, PJH Kusters, L Beckers, M Den Toom, ... Journal of molecular endocrinology 59 (3), 245-255, 2017 | 22 | 2017 |
| Update on the pathophysiology of transfusion-related acute lung injury EANZ van der Laan, S van der Velden, L Porcelijn, JW Semple, ... Current opinion in hematology 27 (6), 386-391, 2020 | 21 | 2020 |
| Circulating CD14+ CD16− classical monocytes do not associate with a vulnerable plaque phenotype, and do not predict secondary events in severe atherosclerotic patients JAL Meeuwsen, JJ de Vries, A van Duijvenvoorde, S van der Velden, ... Journal of molecular and cellular cardiology 127, 260-269, 2019 | 20 | 2019 |
| Targeting histone deacetylases in myeloid cells inhibits their maturation and inflammatory function with limited effects on atherosclerosis R Luque-Martin, J Van den Bossche, RC Furze, AE Neele, ... Frontiers in Pharmacology 10, 1242, 2019 | 19 | 2019 |
| MAb therapy against the IFN-α/β receptor subunit 1 stimulates arteriogenesis in a murine hindlimb ischaemia model without enhancing atherosclerotic burden PFA Teunissen, MC Boshuizen, MR Hollander, PS Biesbroek, ... Cardiovascular research 107 (2), 255-266, 2015 | 19 | 2015 |
